These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


349 related items for PubMed ID: 28572465

  • 1. Relationship Between Polymorphisms in Methotrexate Pathway Genes and Outcome of Methotrexate Treatment in a Cohort of 119 Patients with Juvenile Idiopathic Arthritis.
    Zajc Avramovič M, Dolžan V, Toplak N, Accetto M, Lusa L, Avčin T.
    J Rheumatol; 2017 Aug; 44(8):1216-1223. PubMed ID: 28572465
    [Abstract] [Full Text] [Related]

  • 2. Genetic Determinants of Methotrexate Toxicity in Tunisian Patients with Rheumatoid Arthritis: A Study of Polymorphisms Involved in the MTX Metabolic Pathway.
    Chaabane S, Marzouk S, Akrout R, Ben Hamad M, Achour Y, Rebai A, Keskes L, Fourati H, Bahloul Z, Maalej A.
    Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):385-93. PubMed ID: 26077125
    [Abstract] [Full Text] [Related]

  • 3. Single nucleotide polymorphisms associated with methotrexate-induced nausea in juvenile idiopathic arthritis.
    Kyvsgaard N, Mikkelsen TS, Als TD, Christensen AE, Corydon TJ, Herlin T.
    Pediatr Rheumatol Online J; 2021 Apr 01; 19(1):51. PubMed ID: 33794950
    [Abstract] [Full Text] [Related]

  • 4. Methotrexate (MTX) pathway gene polymorphisms and their effects on MTX toxicity in Caucasian and African American patients with rheumatoid arthritis.
    Ranganathan P, Culverhouse R, Marsh S, Mody A, Scott-Horton TJ, Brasington R, Joseph A, Reddy V, Eisen S, McLeod HL.
    J Rheumatol; 2008 Apr 01; 35(4):572-9. PubMed ID: 18381794
    [Abstract] [Full Text] [Related]

  • 5. Prediction of methotrexate efficacy and adverse events in patients with juvenile idiopathic arthritis: a systematic literature review.
    van Dijkhuizen EH, Wulffraat NM.
    Pediatr Rheumatol Online J; 2014 Apr 01; 12():51. PubMed ID: 25525416
    [Abstract] [Full Text] [Related]

  • 6. Mutations in the MTHFR gene are not associated with Methotrexate intolerance in patients with juvenile idiopathic arthritis.
    Scheuern A, Fischer N, McDonald J, Brunner HI, Haas JP, Hügle B.
    Pediatr Rheumatol Online J; 2016 Feb 29; 14(1):11. PubMed ID: 26928923
    [Abstract] [Full Text] [Related]

  • 7. Associations between gene polymorphisms and treatment outcomes of methotrexate in patients with juvenile idiopathic arthritis.
    Chen Y, Zou K, Sun J, Yang Y, Liu G.
    Pharmacogenomics; 2018 Apr 29; 19(6):529-538. PubMed ID: 29589488
    [Abstract] [Full Text] [Related]

  • 8. Influence of methylenetetrahydrofolate reductase polymorphisms on efficacy and toxicity of methotrexate in patients with juvenile idiopathic arthritis.
    Schmeling H, Biber D, Heins S, Horneff G.
    J Rheumatol; 2005 Sep 29; 32(9):1832-6. PubMed ID: 16142884
    [Abstract] [Full Text] [Related]

  • 9. Prediction of methotrexate intolerance in juvenile idiopathic arthritis: a prospective, observational cohort study.
    van Dijkhuizen EH, Bulatović Ćalasan M, Pluijm SM, de Rotte MC, Vastert SJ, Kamphuis S, de Jonge R, Wulffraat NM.
    Pediatr Rheumatol Online J; 2015 Sep 29; 13():5. PubMed ID: 25745368
    [Abstract] [Full Text] [Related]

  • 10. Polymorphisms within the folate pathway predict folate concentrations but are not associated with disease activity in rheumatoid arthritis patients on methotrexate.
    Stamp LK, Chapman PT, O'Donnell JL, Zhang M, James J, Frampton C, Barclay ML, Kennedy MA, Roberts RL.
    Pharmacogenet Genomics; 2010 Jun 29; 20(6):367-76. PubMed ID: 20386493
    [Abstract] [Full Text] [Related]

  • 11. Influence of polymorphisms within the methotrexate pathway genes on the toxicity and efficacy of methotrexate in patients with juvenile idiopathic arthritis.
    Yanagimachi M, Naruto T, Hara T, Kikuchi M, Hara R, Miyamae T, Imagawa T, Mori M, Kaneko T, Morita S, Goto H, Yokota S.
    Br J Clin Pharmacol; 2011 Feb 29; 71(2):237-43. PubMed ID: 21219404
    [Abstract] [Full Text] [Related]

  • 12. ABCB1 and ABCC3 gene polymorphisms are associated with first-year response to methotrexate in juvenile idiopathic arthritis.
    de Rotte MC, Bulatovic M, Heijstek MW, Jansen G, Heil SG, van Schaik RH, Wulffraat NM, de Jonge R.
    J Rheumatol; 2012 Oct 29; 39(10):2032-40. PubMed ID: 22859359
    [Abstract] [Full Text] [Related]

  • 13. Generation of novel pharmacogenomic candidates in response to methotrexate in juvenile idiopathic arthritis: correlation between gene expression and genotype.
    Moncrieffe H, Hinks A, Ursu S, Kassoumeri L, Etheridge A, Hubank M, Martin P, Weiler T, Glass DN, Thompson SD, Thomson W, Wedderburn LR.
    Pharmacogenet Genomics; 2010 Nov 29; 20(11):665-76. PubMed ID: 20827233
    [Abstract] [Full Text] [Related]

  • 14. SLCO1B1 variants as predictors of methotrexate-related toxicity in children with juvenile idiopathic arthritis.
    Roszkiewicz J, Michałek D, Ryk A, Swacha Z, Szmyd B, Smolewska E.
    Scand J Rheumatol; 2021 May 29; 50(3):213-217. PubMed ID: 33025831
    [Abstract] [Full Text] [Related]

  • 15. Red blood cell folate concentrations and polyglutamate distribution in juvenile arthritis: predictors of folate variability.
    Becker ML, van Haandel L, Gaedigk R, Thomas B, Hoeltzel MF, Lasky A, Dai H, Stobaugh J, Leeder JS.
    Pharmacogenet Genomics; 2012 Apr 29; 22(4):236-46. PubMed ID: 22344247
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Folate pathway enzyme gene polymorphisms and the efficacy and toxicity of methotrexate in psoriatic arthritis.
    Chandran V, Siannis F, Rahman P, Pellett FJ, Farewell VT, Gladman DD.
    J Rheumatol; 2010 Jul 29; 37(7):1508-12. PubMed ID: 20472929
    [Abstract] [Full Text] [Related]

  • 20. The impact of C677T and A1298C MTHFR polymorphisms on methotrexate therapeutic response in East Bohemian region rheumatoid arthritis patients.
    Soukup T, Dosedel M, Pavek P, Nekvindova J, Barvik I, Bubancova I, Bradna P, Kubena AA, Carazo AF, Veleta T, Vlcek J.
    Rheumatol Int; 2015 Jul 29; 35(7):1149-61. PubMed ID: 25618758
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.